Latest filing published 24 Jun 2026 for Centessa Pharmaceuticals plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Mario Alberto Accardi on record concern Centessa Pharmaceuticals plc, in the capacity of chief executive. In total, 14 filings cover trades dated from 24 June 2025 to 24 June 2026.
On the market, this insider has only sold: 5 sales, €505k in total. Other entries cover 4 share grants and 4 option exercises.
On 24 June 2026 came the latest disclosure, a transaction in Centessa Pharmaceuticals plc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations